Read + Share
Amedeo Smart
Independent Medical Education
Kennedy NA, Lin S, Goodhand JR, Chanchlani N, et al. Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD. Gut 2021;70:1884-1893.PMID: 33903149
Email
LinkedIn
Facebook
Twitter
Privacy Policy